A summer camp of children with type 1 diabetes, running a clinical study assessing the efficacy of the bionic pancreas completed today.

This study tested the hypothesis that a wearable automated bionic pancreas system that automatically delivers both insulin and glucagon could improve glycemic control vs. usual care for young people with type 1 diabetes 12-20 in a diabetes camp environment.

In the study, the bionic pancreas, developed by a consortium of partners including Egret Technologies, achieved great results with glycemic control verifying the hypothesis.The 32 participants in the summer campe study – 16 boys at Camp Joslin and 16 girls at Camp Clara Barton –wore the device through all their normal camp activities.  While specific data isn’t yet available, multiple campers told the diabetes blog "diaTribe" that their blood glucose averaged between 100-140 mg/dl while on the bionic pancreas, and they experienced very little hypoglycemia. One participant told the online blog, “I have done my diabetes management for 14 years, and this is exponentially better than I have ever done.”